NDAORALTABLET, EXTENDED RELEASE
Approved
Jul 2014
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 9h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TARGINIQ is an extended-release oral tablet combining oxycodone (an opioid analgesic) with naloxone (an opioid antagonist) for pain management. The naloxone component is designed to deter misuse and reduce the potential for opioid abuse by precipitating withdrawal if the tablet is crushed or dissolved. This combination targets patients requiring sustained opioid pain relief with built-in abuse-deterrent safeguards.
Peak
Product is at peak lifecycle stage with moderate competitive pressure (30), indicating established market presence and stable commercial infrastructure suitable for mid-career commercial roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
TARGINIQ offers career opportunities primarily in commercial, medical affairs, and market access functions for professionals managing mature, established products in a high-scrutiny therapeutic category. Roles will emphasize compliance, payer relationships, and maintaining market position against competitive and regulatory headwinds.
Brand ManagerSales Representative
Worked on TARGINIQ at Purdue Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.